Unlocking the potential of 1,4-naphthoquinones: A comprehensive review of their anticancer properties

Eduardo Angulo-Elizari1, Andreina Henriquez-Figuereo1, Cristina Morán-Serradilla1

  • 1University of Navarra, School of Pharmacy and Nutrition, Department of Pharmaceutical Sciences, Irunlarrea 1, 31008, Pamplona, Spain.

Insights

Researchers explored 1,4-naphthoquinones as potential anticancer drugs. This review details natural and synthetic derivatives, classifying 197 compounds with significant antitumor activity and their mechanisms.

Area of Science:

  • Medicinal Chemistry
  • Organic Chemistry
  • Pharmacology

Background:

  • Cancer remains a global health challenge with existing treatments often lacking efficacy or safety.
  • The development of novel anticancer therapeutics is crucial for improving patient outcomes.
  • 1,4-Naphthoquinone derivatives represent a promising scaffold for new drug discovery.

Purpose of the Study:

  • To review and compile recent studies on the antitumor activity of 1,4-naphthoquinone and its derivatives.
  • To categorize natural and synthetic naphthoquinones based on structural modifications.
  • To analyze the mechanisms of action for these anticancer compounds.

Main Methods:

  • Comprehensive literature search of studies published within the last 10 years.
  • Classification of natural naphthoquinones exhibiting antitumor properties.
  • Systematic categorization of synthetic naphthoquinones by structural variations.
  • Inclusion of metal complexes utilizing naphthoquinones as ligands.

Main Results:

  • Identification and compilation of numerous 1,4-naphthoquinone derivatives with antitumor potential.
  • Classification of 197 synthetic compounds based on their chemical structures.
  • Detailed description of the mechanisms of action for various naphthoquinone derivatives.
  • Consideration of natural naphthoquinones and their metal complexes.

Conclusions:

  • 1,4-Naphthoquinones are a versatile scaffold for developing novel anticancer agents.
  • Structural modifications of the 1,4-naphthoquinone core significantly influence antitumor activity.
  • Further research into these compounds and their metal complexes holds promise for future cancer therapies.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
163
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
277
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
13.3K